Skip to main content

Table 3 ROCKII S1366 phosphorylation nuclear expressions in invasive breast cancers

From: Immunohistochemical evaluation of ROCK activation in invasive breast cancer

  Number Mean % (standard deviation) P a
Age (years)
 <50 90 13.6 (25.8) 0.706
 ≥ 50 129 14.9 (26.2)
Grade    
 1 13 2.7 (6.0) ] 0.220 
] 0.637
 2 136 13.9 (25.5)
 3 70 17.5 (28.6)
Stage
 I/II 147 9.8 (21.5) 0.003
 III/IV 72 23.7 (31.5)
ER    
 Negative 131 23.3 (30.6) 0.002
 Positive 81 9.0 (20.8)
PR
 Negative 112 20.1 (30) 0.017
 Positive 99 8.2 (18.6)
HER2
 Negative 154 11.3 (23) 0.017
 Positive 57 22.8 (31.4)
Ki67
 < 20 % 34 5.9 (13.4) 0.044
 ≥ 20 % 36 17.8 (25.1)
  1. Bold values indicate statistical significance (P < 0.05). ER, estrogen receptor; PR, progesterone receptor. aMann–Whitney test